Jason S Day

Summary

Publications

  1. doi Delayed catastrophic intracerebral hemorrhage preceded by progressive recovery after carotid stenting for acute ischemic stroke
    Jason S Day
    Division of Cerebrovascular Diseases, University of Iowa Hospitals and Clinics, Department of Neurology, Carver College of Medicine
    J Stroke Cerebrovasc Dis 21:151-4. 2012
  2. doi Previous statin use is not associated with an increased prevalence or degree of gradient-echo lesions in patients with acute ischemic stroke or transient ischemic attack
    Jason S Day
    Department of Neurology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
    Stroke 42:354-8. 2011
  3. doi Endovascular stroke therapy: a single-center retrospective review
    Jason S Day
    Department of Neurology, St Joseph Neurology Associates, Kansas City, Missouri, USA
    Neurosurg Focus 30:E10. 2011

Detail Information

Publications3

  1. doi Delayed catastrophic intracerebral hemorrhage preceded by progressive recovery after carotid stenting for acute ischemic stroke
    Jason S Day
    Division of Cerebrovascular Diseases, University of Iowa Hospitals and Clinics, Department of Neurology, Carver College of Medicine
    J Stroke Cerebrovasc Dis 21:151-4. 2012
    ..Hemorrhagic transformation (HT) is a feared complication of reperfusion therapy for treatment of acute ischemic stroke. Generally, HT occurs within 24-36 hours after thrombolysis...
  2. doi Previous statin use is not associated with an increased prevalence or degree of gradient-echo lesions in patients with acute ischemic stroke or transient ischemic attack
    Jason S Day
    Department of Neurology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
    Stroke 42:354-8. 2011
    ..Because statin therapy is associated with increased risk of intracerebral hemorrhage, we investigated whether statin use was also associated with microhemorrhages in patients with acute ischemic stroke or transient ischemic attack...
  3. doi Endovascular stroke therapy: a single-center retrospective review
    Jason S Day
    Department of Neurology, St Joseph Neurology Associates, Kansas City, Missouri, USA
    Neurosurg Focus 30:E10. 2011
    ..5-hour window limit set for intravenous recombinant tissue plasminogen activator. In this paper, the authors report their experience with various endovascular therapies in acute ischemic stroke...